What Develo does well—and what buyers should verify
Develo was founded in 2022 as a pediatric-only technology company. Its platform brings EHR, billing, practice management, and family engagement into a cloud-native system with AI embedded throughout the workflow.
Modern product design.
Develo’s newer interface and browser-based architecture align with current expectations for speed, automation, and usability. Because the platform is younger, practices should verify its performance across complex clinical, billing, reporting, conversion, and exception workflows.
AI-first workflows.
Develo markets embedded scribes, document intelligence, reporting assistance, automated charge capture, and other AI capabilities. Practices should ask which capabilities are live, included, and proven in daily use.
Family-centered tools.
Its product emphasizes family scheduling, sibling relationships, digital intake, payments, and a parent-friendly portal. Practices should ask to see complex family structures, permissions, billing arrangements, and portal scenarios during the demo.
Venture-backed growth.
Develo announced a $14 million Series A round to expand research, development, and customer success. The investment gives Develo resources to accelerate its platform and support growth. As with any fast-growing vendor, practices should ask how service and product continuity will scale alongside the customer base, and what the long-term plans are for the future of the company.
Those are meaningful strengths. At the same time, a recently built platform has had fewer years to prove itself across implementations, payer mixes, reporting programs, and difficult data-conversion scenarios. Practices should evaluate both the quality of the demo and the depth of the operating record behind it.
What Develo’s funding and shorter history mean for buyers
A $14 million Series A gives Develo resources to accelerate product development, customer success, and growth. That investment is a positive sign of investor confidence and gives the company room to keep building. It is still different from the operating history and long-term customer record of a more established vendor.
The takeaway is not that a venture-backed company is inherently unstable. It is that practices should understand how support will scale, how the product roadmap is set, how pricing may evolve, and what commitments protect access to practice data. Those are reasonable questions whenever a practice is considering a younger EHR vendor.
Where TriMed stands apart
A pediatric platform refined since 1996TriMed was not adapted from a general adult EHR. Its pediatric-specific EHR workflows—including templates, growth tracking, immunization workflows, vaccine management, family communication, and pediatric billing tools—have been shaped by years of work with independent practices. That history matters because an EHR must support both routine visits and the unusual operational problems that appear only after years in production.
A public, verified customer record
GetApp currently lists TriMed at 5.0 out of 5.0 across 55 verified reviews, with 5.0 scores for customer support and value for money. At the time this comparison was prepared, Develo did not have a comparable product profile with verified reviews on Capterra, Software Advice, or GetApp. That does not mean Develo customers are dissatisfied. It means buyers have less independent, public evidence to evaluate than they do for TriMed.
Modern AI without giving up a mature platform
The choice is not simply “new AI” versus “old software.” TriMed offers built-in AI documentation and workflow tools alongside customizable templates, reporting, electronic prescribing, vaccine management, scheduling, claims, collections, patient engagement, digital check-in, telemedicine, and mobile access. Practices can adopt AI while keeping their clinical, financial, and patient workflows in one established system.
Broader certification history
Both products are ONC certified. TriMed Complete was certified in 2019 and its published certification includes clinical quality measure recording, calculation, and reporting criteria. Develo EHR v3 was certified in 2025. Develo’s published certification page lists a more focused set of criteria and does not list clinical quality measure criteria. Practices participating in MIPS or value-based programs should ask both vendors to demonstrate the exact reporting workflows they will use.
Implementation and ongoing support
TriMed owns, implements, and supports its software. Its pediatric EHR implementation and data migration process covers configuration, role-based training, go-live planning, and ongoing support. For an independent practice with limited internal IT resources, that continuity can matter as much as the feature list.
Which pediatric EHR should you choose?
Practices evaluating Develo EHR alternatives should start with their operational priorities.
Consider Develo EHR if your practice strongly favors a newer AI-native interface and is comfortable choosing a younger, venture-backed platform with a shorter operating history and smaller independent review record.
Consider TriMed if your practice wants pediatric-specific workflows, modern AI tools, an integrated EHR and practice-management platform, a verified 5.0/5.0 customer rating, and a vendor with nearly 30 years of implementation and support experience.
Questions to ask during both demos
- Can you demonstrate a complete well-visit workflow, including screenings, immunizations, growth charts, orders, documentation, and charge capture?
- Which AI capabilities are included, which are add-ons, and how is patient data handled?
- What data will be converted, how will it be validated, and who owns each step?
- How do support escalation, after-hours coverage, and response expectations work?
- Can you show the exact MIPS, quality, and operational reports our practice will use?
- What is the total cost over three years, including interfaces, implementation, training, AI, and support?
The bottom line
Develo is a credible newer option with a modern AI-first approach and capital to support continued growth. TriMed offers pediatric specialization and modern AI on top of nearly three decades of operating history, a broad integrated feature set, and a strong body of verified customer reviews. For practices that value proof, continuity, and support alongside modernization, TriMed remains the more established and proven choice.
See how TriMed would fit your practice: Schedule a pediatric EHR demo.
Frequently Asked Questions
Are TriMed and Develo both pediatric-specific EHRs?
Yes. Both platforms are designed specifically for pediatric practices rather than adapted from a general adult EHR.
Does TriMed offer AI tools like Develo?
Yes. TriMed offers built-in AI documentation and workflow tools. Develo also markets an AI suite that includes an embedded scribe and automation across clinical, billing, and reporting workflows.
Are TriMed and Develo ONC certified?
Yes. TriMed Complete was certified in 2019, while Develo EHR v3 was certified in 2025. Practices should compare the specific certification criteria and reporting capabilities relevant to their programs.
What should practices compare when evaluating pediatric EHR alternatives?
Compare pediatric workflow depth, implementation and data-migration support, AI maturity, reporting, independent reviews, total cost, and ongoing support. The best pediatric EHR is the one that fits both clinical and financial operations—not simply the newest interface.
Which system has more independent customer reviews?
TriMed has the larger public review record. GetApp lists TriMed at 5.0 out of 5.0 across 55 verified reviews. Develo did not have a comparable Capterra, Software Advice, or GetApp product-review profile when this article was prepared.